CME Group (CME) is an early-stage, interest-sensitive stock set to see accelerating revenues from rising interest rates and the regulation of OTC derivatives, says Brad Hintz, Equity Research Analyst at Sanford Bernstein & Co., LLC.
“The CME has a 98% market share of U.S. dollar interest rate futures. As investors anticipate rising U.S. interest rates, hedging activity on the exchange will increase, and CME revenues will accelerate,” Hintz said.
FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.
Hintz says that CME is near a turning point, as it offers hedging products to the marketplace and as the economy recovers, hedging will become more important. Additionally, CME will be a winner out of the regulation of OTC derivatives, Hintz says.
“We expect the revenues from CME central clearing platform to rise sharply over the next two years both from direct clearing fees but also from the expected electronic linkage of CCP-cleared OTC derivatives and the listed futures market,” Hintz said.
SVB Financial Group (SIVB) Grows Double Digits and May Soar Profits if Interest Rates Rise
March 06, 2013
Penetration Rates Rise for BPO & Outsourcing
May 27, 2011
RigNet (RNET) Reports 36% EBITDA Increase; Expects to Benefit from Oilfield Data Throughput Rise
July 24, 2013
Rio Tinto PLC (NYSE:RIO), Fortescue Metals Group Ltd. (OTC:FSUGY, ASE:FGM) Offer Exposure to Low-Cost Iron Ore Producers
December 18, 2013
PDL BioPharma (PDLI) Closes Revenue-Generating Deal with AxoGen (OTC:AXGN)
October 10, 2012
